Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases.
This report contains market size and forecasts of Decernotinib(JAK3 Inhibitor) in global, including the following market information:
Global Decernotinib(JAK3 Inhibitor) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Decernotinib(JAK3 Inhibitor) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Decernotinib(JAK3 Inhibitor) companies in 2021 (%)
The global Decernotinib(JAK3 Inhibitor) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Decernotinib(JAK3 Inhibitor) include Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, APExBIO Technology, Selleck Chemicals, AbMole, BOC Sciences and Taiclone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Decernotinib(JAK3 Inhibitor) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decernotinib(JAK3 Inhibitor) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Decernotinib(JAK3 Inhibitor) Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Decernotinib(JAK3 Inhibitor) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Decernotinib(JAK3 Inhibitor) Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Decernotinib(JAK3 Inhibitor) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Decernotinib(JAK3 Inhibitor) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decernotinib(JAK3 Inhibitor) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Decernotinib(JAK3 Inhibitor) revenues share in global market, 2021 (%)
Key companies Decernotinib(JAK3 Inhibitor) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Decernotinib(JAK3 Inhibitor) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cayman Chemical
Adooq Bioscience
BioVision
Biorbyt
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
Taiclone
LKT Laboratories
TargetMol
Wuhan Sun-Shine Bio-Technology